相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 Claudin18.2/CLDN18.2 抗体 (佐妥昔单抗),生物类似药,科研用途 [ CAS: 1496553-00-4]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Chimeric
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
Claudin18.2/CLDN18.2
- 抗体名:
Claudin18.2/CLDN18.2
- 规格:
5mg
商品核心信息
英文名称:BioSIM anti-Human Claudin18.2/CLDN18.2 Antibody (Zolbetuximab Biosimilar), Research Grade
中文名称:BioSIM 抗人 Claudin18.2/CLDN18.2 抗体 (佐妥昔单抗),生物类似药,科研用途
CAS号:1496553-00-4
产品货号:SIM0057-5mg
产品规格:5mg
供应商:InvivoCrown
产品类型:二抗
背景与应用
背景资料
该产品为佐妥昔单抗非治疗性生物仿制药,与佐贝妥昔单抗具有相同的可变区,适配科研场景需求。其可与人紧密连接蛋白18.2(CLDN18.2,紧密连接蛋白家族成员)发生特异性反应——CLDN18.2主要表达于胃/胰腺癌组织,仅在健康胃黏膜中存在;紧密连接蛋白参与调控细胞间紧密连接及肿瘤形成过程,表达异常可促进上皮癌发生发展。
佐贝妥昔单抗在人源化前列腺癌小鼠模型中,已观察到通过ADCC(抗体依赖的细胞介导的细胞毒性作用)/CDC(补体依赖的细胞毒性作用)呈现的抗肿瘤活性。
研究领域
食管胃结合部肿瘤、胃癌、胆管癌
应用类型
ELISA、FACS、Functional assay、Research in vivo
产品特性
免疫原
请参考该产品的说明书
来源宿主
Chimeric(嵌合型)
反应性
Human(人源)
储存建议
为保障产品稳定性,需避免反复冻融:
- 短期需求(1-2周):4°C保存
- 最长12个月储存:-20°C保存
- 长期储存:-80°C保存
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

Product Core Information
English Name:BioSIM anti-Human Claudin18.2/CLDN18.2 Antibody (Zolbetuximab Biosimilar), Research Grade
Chinese Name:BioSIM anti-Human Claudin18.2/CLDN18.2 Antibody (Zolbetuximab), Biosimilar, Research Grade
CAS Number:1496553-00-4
Catalog Number:SIM0057-5mg
Size:5mg
Supplier:InvivoCrown
Product Type:Secondary Antibody
Background and Application
Background Information
This product is a non-therapeutic biosimilar of zolbetuximab, sharing the same variable region as zolbetuximab, suitable for research applications. It specifically reacts with human tight junction protein 18.2 (CLDN18.2, a member of the tight junction protein family). CLDN18.2 is primarily expressed in gastric/pancreatic cancer tissues and exists only in healthy gastric mucosa. Tight junction proteins are involved in regulating intercellular tight junctions and tumorigenesis, and abnormal expression can promote the development and progression of epithelial cancers.
In humanized prostate cancer mouse models, zolbetuximab has demonstrated antitumor activity through ADCC (Antibody-Dependent Cell-mediated Cytotoxicity)/CDC (Complement-Dependent Cytotoxicity).
Research Areas
Esophagogastric junction tumors, gastric cancer, cholangiocarcinoma
Application Types
ELISA, FACS, Functional assay, Research in vivo
Product Characteristics
Immunogen
Please refer to the product manual
Source Host
Chimeric
Reactivity
Human
Storage Recommendations
To ensure product stability, avoid repeated freeze-thaw cycles:
- Short-term use (1-2 weeks): Store at 4°C
- Up to 12 months storage: Store at -20°C
- Long-term storage: Store at -80°C
Note: The above information may change due to product optimization and upgrades. Please consult InvivoCrown for specific information.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料







